AngioDynamics Inc. (ANGO)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
16.54-0.23 (-1.37%)
At close: 4:00 PM EDT
People also watch:
ATRCMMSIELGXCUTRCMN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open16.78
Prev Close16.77
Bid16.16 x 400
Ask0.00 x
Day's Range16.41 - 16.96
52wk Range9.71 - 17.05
1y Target EstN/A
Market Cap602.43M
P/E Ratio (ttm)-13.67
Beta1.18
Volume104,407
Avg Vol (3m)239,752
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube14 hours ago

    ETF’s with exposure to AngioDynamics, Inc. : August 31, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to AngioDynamics, Inc. Here are 5 ETF’s with the largest exposure to ANGO-US. Comparing the performance and risk of AngioDynamics, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • American City Business Journals14 days ago

    AngioDynamics on hiring spree at Queensbury plant after competitor's recall

    AngioDynamics has hired 50 workers, brought back a retired supervisor and is looking for 25 more people to help make angiographic catheters used in medical imaging procedures. The company is getting a boost to its revenue after a competitor, Cook Medical, recalled many of its angiographic products. "We've beefed up our second shift … because those lines were just idle on the second shift so that's where we put our labor, and we've been running into overtime so we can get those other 20 to 25 folks in and trained," said Jeremy Sharp, the director of the company's New York operations.

  • GlobeNewswire23 days ago

    AngioDynamics to Present at the 2016 Canaccord Genuity Growth Conference

    ALBANY, N.Y., Aug. 08, 2016-- AngioDynamics, a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today ...